Strobeck Mark
Transaction: 07/01/2026
BUY
Change
+30,000
Price
Not reported
Filing
07/06/2026
Type
BUY
Rockwell Medical, Inc.
RMTI • Drug Manufacturers - Specialty & Generic
$7.99
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$31.61M
Growth
-4.7%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.34Healthy liquidity · 3.98Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:33 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$7.99
Change0.00%
Shares Out3.96M
Market Cap$31.61M
Enterprise Value$-24.76B
52W Range4.89 - 21.00
Beta1.62
P/E-0.03
P/S0.00
P/B0.00
P/FCF12.24
EV/Sales-1.39
Price$7.99
Change0.00%
Shares Out3.96M
Market Cap$31.61M
Enterprise Value$-24.76B
52W Range4.89 - 21.00
Beta1.62
P/E-0.03
P/S0.00
P/B0.00
P/FCF12.24
EV/Sales-1.39
EV/EBITDA23.29
EV/FCF-9,587.58
FCF Yield8.17%
Dividend Yield0.00%
Gross Margin16.89%
Oper. Margin-6.77%
Profit Margin-7.67%
Debt/Eq0.34
Current Ratio3.98
Quick Ratio3.63
Revenue 5Y-4.67%
Target$20.00
Target Upside150.47%
Target Median$20.00
Target Range20.00 - 20.00
Volume81.20K
Avg Volume30.82K
EPS Surprise-0.03
Investment DNA
How strong this company looks for long-term investors
44
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
75/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.34Healthy liquidity · 3.98Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 16 analyst votes · 2026-09-05
69/100
Neutral
Bullish
10
Hold
2
Bearish
4
Price Target
2026-08-14
Low
$20.00
Mean
$20.00
Median
$20.00
High
$20.00
Insider Transactions
Recent executive and insider activity
Neri Jesse
Transaction: 07/01/2026
BUY
Change
+15,000
Price
Not reported
Filing
07/06/2026
Type
BUY
TIMMINS MEGAN C.
Transaction: 07/01/2026
BUY
Change
+15,000
Price
Not reported
Filing
07/06/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Strobeck Mark | BUY | +30,000 | Not reported | 07/01/2026 | 07/06/2026 |
| Neri Jesse | BUY | +15,000 | Not reported | 07/01/2026 | 07/06/2026 |
| TIMMINS MEGAN C. | BUY | +15,000 | Not reported | 07/01/2026 | 07/06/2026 |
| Hunter Heather | BUY | +15,000 | Not reported | 07/01/2026 | 07/06/2026 |
| Chole Timothy | BUY | +15,000 | Not reported | 07/01/2026 | 07/06/2026 |
| COOPER JOHN G | BUY | +9,633 | Not reported | 07/01/2026 | 07/06/2026 |
| Radie Robert S | BUY | +9,633 | Not reported | 07/01/2026 | 07/06/2026 |
| Lau Joan | BUY | +9,633 | Not reported | 07/01/2026 | 07/06/2026 |
| Nissenson Allen | BUY | +9,633 | Not reported | 07/01/2026 | 07/06/2026 |
| Dawson Joseph H | BUY | +9,633 | Not reported | 07/01/2026 | 07/06/2026 |
| Strobeck Mark | BUY | +352,000 | Not reported | 05/20/2025 | 04/17/2026 |
| Chole Timothy | BUY | +85,000 | Not reported | 05/20/2025 | 04/17/2026 |
| TIMMINS MEGAN C. | BUY | +97,500 | Not reported | 05/20/2025 | 04/17/2026 |
| Neri Jesse | BUY | +97,500 | Not reported | 05/20/2025 | 04/17/2026 |
| Strobeck Mark | SELL | -7,333 | $0.90 | 03/14/2026 | 03/16/2026 |
| Chole Timothy | SELL | -2,444 | $0.90 | 03/14/2026 | 03/16/2026 |
| Neri Jesse | SELL | -2,444 | $0.90 | 03/14/2026 | 03/16/2026 |
| TIMMINS MEGAN C. | SELL | -3,667 | $0.90 | 03/14/2026 | 03/16/2026 |
| Hunter Heather | SELL | -2,444 | $0.90 | 03/14/2026 | 03/16/2026 |
| Neri Jesse | SELL | -886 | $0.84 | 01/02/2026 | 01/05/2026 |